{"nctId":"NCT01629966","briefTitle":"Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder","startDateStruct":{"date":"2012-06-30","type":"ACTUAL"},"conditions":["Generalized Anxiety Disorder"],"count":680,"armGroups":[{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]},{"label":"Vilazadone 20mg","type":"EXPERIMENTAL","interventionNames":["Drug: Vilazodone"]},{"label":"Vilazodone 40mg","type":"EXPERIMENTAL","interventionNames":["Drug: Vilazodone"]}],"interventions":[{"name":"Placebo","otherNames":[]},{"name":"Vilazodone","otherNames":[]},{"name":"Vilazodone","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male and female, 18 - 70 years of age\n* Currently meet the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria for Generalized Anxiety Disorder (GAD)\n* Minimum score of 20 on the Hamilton Rating Scale for Anxiety (HAM-A)\n\nExclusion Criteria:\n\n* Women who are pregnant, women who will be breastfeeding during the study and women of childbearing potential who are not practicing a reliable method of birth control\n* History of meeting DSM-IV-TR criteria for any of the following:\n\n  * Any manic or hypomanic or mixed episode, including bipolar disorder and substance-induced manic, hypomanic or mixed episode\n  * Any depressive episode with psychotic or catatonic features\n  * Panic disorder with or without agoraphobia\n  * Obsessive-compulsive disorder\n  * Schizophrenia, schizoaffective, or other psychotic disorder\n  * Bulimia or anorexia nervosa\n  * Presence of borderline personality disorder or antisocial personality disorder\n  * Mental retardation, dementia, amnesia, or other significant cognitive disorders\n* Patients who are considered a suicide risk","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"70 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in the Hamilton Rating Scale for Anxiety (HAM-A) Total Score","description":"The Hamilton Anxiety Rating Scale (HAM-A) is a clinician-administered scale which consists of 14 items, each rated on a five point scale ranging from 0 (not present) to 4 (very severe). The highest possible score is 56, which represents the most severe form of anxiety; the lowest possible score is 0, which represents an absence of anxiety.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13.1","spread":"7.93"},{"groupId":"OG001","value":"12.0","spread":"7.13"},{"groupId":"OG002","value":"11.2","spread":"7.46"}]}]}]},{"type":"SECONDARY","title":"Change From Baseline in the Sheehan Disability Scale (SDS) Total Score","description":"The Sheehan Disability Scale (SDS) is a 3-item clinician-rated questionnaire used to evaluate impairments in the domains of work, social life/leisure, and family life/home responsibility. All items are rated on an 11-point continuum (0 = no impairment to 10 = most severe) with the total SDS score ranging from 0 (no impairment) to 30 (most severe).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.4","spread":"7.53"},{"groupId":"OG001","value":"7.7","spread":"6.51"},{"groupId":"OG002","value":"6.7","spread":"6.62"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":221},"commonTop":["Nausea","Diarrhoea","Headache","Dizziness","Upper respiratory tract infection"]}}}